Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Piromidic acid

19562-30-2C14H16N4O3288.307 g/mol

A pyridopyrimidine that is 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid, substituted at position 2 by a pyrrolidin-1-yl group and at position 8 by an ethyl group. A synthetic antibacterial which is used for the treatment of urinary tract and intestinal infections. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number19562-30-2ChEBI ↗
Molecular formulaC14H16N4O3ChEBI ↗
Molar mass288.307 g/molChEBI ↗
Monoisotopic mass288.12224 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:32019ChEBI ↗

Cross-source molecular data

PubChem
Molar mass288.30 g/molPubChem ↗
Exact mass288.12224039 DaPubChem ↗
Computed XLogP1.3PubChem ↗
Topological polar surface area (Ų)86.6PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors7PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
piromidic acid
8-ethyl-5-oxo-2-(pyrrolidin-1-yl)-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid
RCIMBBZXSXFZBV-UHFFFAOYSA-N
CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21
InChI=1S/C14H16N4O3/c1-2-17-8-10(13(20)21)11(19)9-7-15-14(16-12(9)17)18-5-3-4-6-18/h7-8H,2-6H2,1H3,(H,20,21)

Names & synonyms

8-ethyl-5-oxo-2-(pyrrolidin-1-yl)-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acidacide piromidiqueacido piromidicoacidum piromidicumActrun CBactramylEnterolGastrurolPanacidReelonSepturalUropir

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antibacterial agentantibacterial drugDNA synthesis inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00346852 mol

Uses 288.307 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 14 atoms
58.32%
N
Nitrogen · 4 atoms
19.43%
O
Oxygen · 3 atoms
16.65%
H
Hydrogen · 16 atoms
5.59%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Metabolism in rats and man of piromidic acid, a new antibacterial agent. ↗Xenobiotica; the fate of foreign compounds in biological systems · 1976 Mar · PMID 1274382

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:32019

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 4855 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.